69. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit der Mexikanischen und Kolumbianischen Gesellschaft für Neurochirurgie
Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.
03.06. - 06.06.2018, Münster
Vorträge Mittwoch, 06.06.2018
Gliomas: Experimental V
Meeting Abstract
(V303)
[Full Text]
Clinical impact of TERT promoter mutation detection in cell-free DNA of patients with IDH wild-type glioblastomas – a pilot prospective study
Krex D, Juratli T, Juratli M, Makina M, Schackert G, Lautenschlaeger T, Thiede C[Full Text]
Meeting Abstract
(V304)
[Full Text]
MRI-derived oxygen metabolism and neovascularization characterizes grading and idh gene mutation status in gliomas
Rössler K, Zimmermann M, Dörfler A, Oberndorfer S, Heinz G, Buchfelder M, Stadlbauer A[Full Text]
Meeting Abstract
(V305)
[Full Text]
Efficacy of Tumor Treating Fields (TTFields) and aurora B kinase inhibitor in glioma cells
Krex D, Temme A, Schneidermann R, Giladi M, Kinzel A, Kirson E, Palti Y[Full Text]
Meeting Abstract
(V306)
[Full Text]
Touchless optical assessment of the IDH1 mutation status of experimental gliomas
Yao W[Full Text]
Meeting Abstract
(V307)
[Full Text]
Implementation of the modified PRESS sequence for the IDH Spectroscopy
Zolal A, Krex D, Schackert G, Podlesek D, Juratli T, Linn J, Werner A[Full Text]
Meeting Abstract
(V308)
[Full Text]
The expression of CD40 correlates negatively with overall survival of low- and high-grade gliomas
Timmer M, Werner JM, Kuhl S, Krischek B, Goldbrunner R[Full Text]
Meeting Abstract
(V309)
[Full Text]
Immunological changes during tumor progression from primary to recurrent glioblastoma
Warta R, Rapp C, Jungk C, Okada H, Glass R, Herold-Mende C, Unterberg AW[Full Text]
